CD33 and Alzheimer disease: Accumulating evidence suggests a critical role for microglia in the pathogenesis of AD, and latest human genetics data have identified several novel AD risk genes such as CD33 or CR1, which are highly expressed by these brain resident immune cells (reviewed in [21]).